Presented Friday, January 24, 2020
HPG80 (Progastrin), a novel blood-based biomarker for detection of neuroendocrine neoplasms.
GI ASCO / Presented Friday, January 24, 2020
Presented our data on a new and exciting blood based diagnostics biomarker for both high and low grade neuroendocrine neoplasms. hPG80 (Progastrin). Got to collaborate with excellent scientists across Atlantic. #GI20 @alex_prieur @LowellAnthonyMD @SusanneArnoldMD @JMKolesar
First Author: Aman Chauhan, MBBS
Meeting: 2020 Gastrointestinal Cancers Symposium
Session Type: Poster Session
Session Title: Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track: Neuroendocrine/Carcinoid
Subtrack: Tumor Biology, Biomarkers, and Pathology
Abstract #: 628
link to abstract : https://meetinglibrary.asco.org/record/182207/abstract